MedPath

Effect of Nutritional Formula (Protison) on Various Cancer Patients: A Randomized Clinical Trial

Not Applicable
Completed
Conditions
Cancer
Interventions
Dietary Supplement: Protison cancer nutritional formula (PCNF)
Registration Number
NCT04643613
Lead Sponsor
Chung Shan Medical University
Brief Summary

Many studies (including ASPEN/ESPEN) have demonstrated that balanced diet formula rich in omega 3 fatty acids (ω-3 FA), fibers, protein as well as mineral, vitamins (trace elements) are essential for cancer patients to improve health status and tolerability of chemotherapy. Hence, the present multi-centered, randomized clinical trial was framed to evaluate the efficacy of ready to use balanced nutritional formula-PCNF (rich in ω-3 FA, fibers, MTC, BCAA, and micro-nutrients), in various cancer patient by checking calorie intake and overall health status through assessing various anthropometric and biochemical parameters especially total proteins, pre-albumin, and transferrin.

Detailed Description

Many studies (including ASPEN/ESPEN) have demonstrated that balanced diet formula rich in omega 3 fatty acids (ω-3 FA), fibers, protein as well as mineral, vitamins (trace elements) are essential for cancer patients to improve health status and tolerability of chemotherapy. Hence, oncologic nutritionist strongly recommends cancer patients (with cachexia) to consume a diet rich in protein and dietary fibers along with balanced essential micronutrients like vitamins and minerals (Van Norren et al., 2009; Yeh et al., 2013). From the above statement, it cleared that nutritional support is a crucial aspect of multi-modal cancer care, by improving the overall health status by suppressing various adverse events as well as enhance treatment regimen for a speedy recovery. Hence, the present multi-centered, randomized clinical trial was framed to evaluate the efficacy of ready to use balanced nutritional formula-PCNF (rich in ω-3 FA, fibers, MTC, BCAA, and micro-nutrients), in various cancer patient by checking calorie intake and overall health status through assessing various anthropometric and biochemical parameters especially total proteins, pre-albumin, and transferrin.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
42
Inclusion Criteria
  • only hospitalized cancer patients with risk of malnutrition and underweight (confirmed with BMI, protein, and pre-albumin level) and must be under NG tube feeding.
Exclusion Criteria
  • avoiding cancer patients under critical conditions, with cardiac, renal, and hepatic disorders. Also, heavy smokers, chronic or chain smokers, and pregnant/lactating women were not included.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
PCNFProtison cancer nutritional formula (PCNF)Totally 42 cancer patients with poor nutritional status under nasogastric (NG) tube feeding was recruited and administered with the commercial nutritional formula (PCNF; 237 mL/Pack) for 5-6 times/day via bolus NG tube feeding for 12 weeks (84 days).
Primary Outcome Measures
NameTimeMethod
Calorie intake12 weeks

The mean value of calorie intake (energy) were significantly increased in PCNF supplemented subjects

Anthropometric parameters12 weeks

BMI were markedly improved in PCNF intook subjects

Protein nutritional assessment index or nutritional status12 weeks

Protein nutritional assessment index (total protein, pre-albumin , and transferrin) were significantly improved

Secondary Outcome Measures
NameTimeMethod
Glycemic indices12 weeks

No significant changes in any of the glycemic indices or lipid profile PCNF groups

Trial Locations

Locations (1)

Chung Shan Medical University

🇨🇳

Taichung city, Taichung, Taiwan

© Copyright 2025. All Rights Reserved by MedPath